Therapeutic benefits of a component of coffee in a rat model of Alzheimer disease()

A minor component of coffee unrelated to caffeine, eicosanoyl-5-hydroxytryptamide (EHT) provides protection in a rat model for Alzheimer’s disease (AD). In this model, viral expression of the phosphoprotein phosphatase 2A (PP2A) endogenous inhibitor, the I(2)(PP2A) or SET protein in the brains of ra...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurobiol Aging
Main Authors: Basurto-Islas, Gustavo, Blanchard, Julie, Tung, Yunn Chyn, Fernandez, Jose R., Voronkov, Michael, Stock, Maxwell, Zhang, Sherry, Stock, Jeffry B., Iqbal, Khalid
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254318/
https://ncbi.nlm.nih.gov/pubmed/25034344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2014.06.012
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares